Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,582 | 1,965 | 11,986 | 12,117 | 2,366 |
| Cost of Goods | 59 | 0 | 1,000 | 1,000 | 0 |
| Gross Profit | 2,523 | 1,965 | 10,986 | 11,117 | 2,366 |
| Operating Expenses | 5,424 | 4,187 | 5,153 | 4,157 | 5,580 |
| Operating Income | -2,842 | -2,222 | 5,833 | 6,960 | -3,214 |
| Interest Expense | 5 | 6 | 16 | 349 | 1,747 |
| Other Income | 178 | 469 | 386 | -16,907 | 105 |
| Pre-tax Income | -2,669 | -1,759 | 6,203 | -10,296 | -4,856 |
| Net Income Continuous | -2,703 | -1,759 | 6,203 | -10,296 | -4,856 |
| Net Income | $-2,703 | $-1,759 | $6,203 | $-10,296 | $-4,856 |
| EPS Basic Total Ops | 0.83 | -0.05 | -0.40 | -2.49 | -0.82 |
| EPS Basic Continuous Ops | 0.09 | -0.05 | 0.21 | -0.54 | -0.83 |
| EPS Diluted Total Ops | 0.83 | -0.05 | -0.40 | -2.49 | -0.82 |
| EPS Diluted Continuous Ops | 0.09 | -0.05 | 0.21 | -0.54 | -0.83 |
| EBITDA(a) | $-2,778 | $-2,157 | $5,897 | $7,174 | $-2,566 |